Health & Biotech Success Stories

Antabio Logo
Antabio

€10.5 Million

Horizon Europe: EIC Accelerator

A combination treatment effective against all critical multidrug-resistant pathogens

Antabio develops a combination of existing antibiotics and their proprietary, best-in-class serine-β-lactamase inhibitor, which makes pathogens susceptible to antimicrobials, intended for the treatment of hospital-acquired infections caused by drug-resistant pathogens.

Their treatment has been pre-clinically proven to be efficacious against Gram-negative antimicrobial-resistant bacteria.

Adjucor Logo
Adjucor

€2.5 Million

Horizon Europe: EIC Accelerator

Effective and affordable treatment for heart failure

Adjudicator delivers reBEAT, a revolutionary technology to mechanically support both sides of the heart, which does not directly contact blood and can be easily implanted.

Their system offers high cost-effectiveness at <50% of the cost of heart transplantations and ventricular assist devices, which are the gold standard treatment today.

Plair Logo
Plair

€2.5 Million

SERI: Accelerator Grant

Real-time monitoring and risk assessment for air contamination control

Plair created specialised solutions for detection and early warning of changes in air quality for sterile manufacturing and research

Their technology has a wide range of applications from detection of bioaerosols and allergens, to microbial detection with the benefit of autonomous measurements for increased accuracy and reliability.

Page 6 of 6

Zaz Ventures Central

Square de Meeus 35
1000 Brussels
Belgium

+32 6 98 100 87

Zaz Ventures West

24 Greville Street
EC1N 8SS London
United Kindom

+44 20 3286 2807

Zaz Ventures South

Hansmatt 32
6370 Stans
Switzerland

+41 315 190 109

Zaz Ventures East

7 Temasek Boulevard
#12-07 Suntec Tower One
Singapore

+65 9779 1309

Zaz Ventures supports the EIC Code of Conduct

© 2024 Zaz Ventures. All Rights Reserved
| Privacy Policy | Sitemap

Follow us on Linkedin Follow us on X Follow us on Youtube